Key result
Higher childhood adiponectin levels were inversely associated with preclinical carotid atherosclerosis in adulthood (OR 0.68; 95% CI 0.53-0.86; p=0.001 per 1-SD increase).
Why the study?
Do childhood adiponectin levels predict preclinical carotid atherosclerosis in adulthood?
Cohort (n=1,708)
Do childhood adiponectin levels predict preclinical carotid atherosclerosis in adulthood?
Effect estimate: OR 0.68 (95% CI 0.53-0.86)
p-value: p=.001
Childhood adiponectin levels independently predict the development of preclinical carotid atherosclerosis in adulthood, improving risk prediction over conventional risk factors.
Childhood adiponectin may aid long-term atherosclerosis risk assessment; leaves open whether it adds value beyond standard factors in clinical practice.
INTRODUCTION: Low adiponectin levels may predict the development of atherosclerosis. We examined the association of childhood adiponectin with preclinical carotid atherosclerosis that is defined as plaque and/or high (≥95th percentile) intima-media thickness (IMT) at the carotid bifurcation in adulthood. METHODS: The Cardiovascular Risk in Young Finns Study is a cohort study on cardiovascular risk factors. We used risk factor data from the baseline study (1980) and ultrasound findings from the follow-ups (2001 and 2007). The study population included 1708 participants, aged 3-18 years at baseline. RESULTS: In multivariate analysis, childhood adiponectin was inversely associated with preclinical carotid atherosclerosis: odds ratio 0.68, 95% confidence interval (CI) 0.53-0.86, p = .001, for 1-SD increase in childhood adiponectin after adjusting for childhood non-high-density lipoprotein cholesterol, body mass index, and blood pressure. When examining the incremental predictive ability, we observed that compared to an approach utilizing only conventional risk factors, the model additionally including adiponectin levels improved c-statistics area under curve from 0.733 (95% Cl 0.694-0.771) to 0.748 (95% Cl 0.710-0.786), p = .02. CONCLUSIONS: Childhood adiponectin levels improve the prediction of carotid atherosclerosis in adulthood over conventional risk factors. This supports the idea that low adiponectin levels may have a role in the development of preclinical atherosclerosis. Key messages Childhood adiponectin levels improve the prediction of increased carotid intima-media thickness in adulthood over conventional cardiovascular risk factors. These results suggest that adiponectin levels measured in childhood may have a role in the atherosclerotic process.
No takes yet. Share an insight, caveat, or question.
Saarikoski et al. (2016) conducted a cohort in Preclinical carotid atherosclerosis (n=1,708). Childhood adiponectin levels vs. Conventional risk factors was evaluated on Preclinical carotid atherosclerosis (plaque and/or ≥95th percentile intima-media thickness at the carotid bifurcation) (OR 0.68, 95% CI 0.53-0.86, p=.001). Higher childhood adiponectin levels were inversely associated with preclinical carotid atherosclerosis in adulthood (OR 0.68; 95% CI 0.53-0.86; p=0.001 per 1-SD increase).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: